PROTEGA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Apr 2025 filing date already counts against anyone who files later.

Record

Serial number

99151046

Mark type

Stylized text

Filed

23 Apr 2025

Published for opposition

20 Jan 2026

Attorney of record

Brian J. Focarino

Goods and services

• Class 005 — Pharmaceuticals: Medical diagnostic blood or biopsy testing assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; all of the goods related to the field of organ transplants
• Class 010 — Medical apparatus: Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients; all of the goods related to the field of organ transplants
• Class 042 — Scientific and technological services: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; all of the services related to the field of organ transplants
• Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies for predicting and identifying risk of graft rejection in kidney transplant patients; healthcare, namely, medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients

Owner

• Verici Dx Plc, Cardiff, GB
• Verici Dx Plc, Cardiff, GB

Prosecution history

• 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 20 Jan 2026 — PUBLISHED FOR OPPOSITION
• 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 18 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 18 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
• 18 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 18 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
• 18 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
• 18 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 18 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 18 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Sept 2025 — NON-FINAL ACTION E-MAILED
• 18 Sept 2025 — NON-FINAL ACTION WRITTEN